The FDA has approved Roche’s MRSA test, a technology that could give healthcare providers the ability to detect infections faster than traditional culture-based tests.
An expert has said the UK must pay upwards of $25 million per year to drug companies developing new antibiotics under its soon-to-be announced "Netflix" subscription model, which aims to gi
Takeda’s dengue vaccine has met its target of protection against the disease in children – but there are already concerns about mixed results among different strains of the potentially dead
GlaxoSmithKline (GSK) has sold off two travel vaccines to Bavarian Nordic, as the company shifts its focus away from drugs it acquired through a multi-billion “asset swap” deal with Novarti
UK researchers are beginning a trial investigating whether a course of antibiotics prior to conceiving could cut likelihood of miscarriage in up to half of cases.